AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing TumorsWeining Weng, Xun Meng|Molecular Cancer Therapeutics|2023Cited by 24
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody–Drug Conjugate for Targeting MelanomaJing Shi, Xun Meng|Cancer Research|2023Cited by 14